Global Burden of Disease 2023: Insights and Applications

Abstract This presentation provides an overview of the Global Burden of Disease Study and the key findings from its most recent iteration (GBD 2023) from the perspective of the Institute for Health Metrics and Evaluation (IHME). The presenters will discuss the global significance of the study and highlight key findings. The session will provide attendees with insight into the GBD 2023 study's objectives, its contributions to global health research, and its usefulness as a basis for evidence-based public health policy.